• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患儿和对照儿童的肠道蛋白质组富含不同的微生物蛋白和宿主蛋白。

The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins.

作者信息

Pinto Elsa, Anselmo Marisol, Calha Manuela, Bottrill Andrew, Duarte Isabel, Andrew Peter W, Faleiro Maria L

机构信息

Faculdade de Ciências e Tecnologia, Centro de Investigação em Biomedicina, Universidade do Algarve Campus de Gambelas, 8005-139 Faro, Portugal.

Núcleo de Diabetologia, Nutrição e Doenças Metabólicas (NDNDM) do Hospital de Faro, 8000-386 Faro, Portugal.

出版信息

Microbiology (Reading). 2017 Feb;163(2):161-174. doi: 10.1099/mic.0.000412.

DOI:10.1099/mic.0.000412
PMID:28270263
Abstract

In this study, the intestinal microbial proteome of children with established type 1 diabetes (T1D) was compared with the proteome of healthy children (Control) with the aim to identify differences in the activity of the intestinal microbiota that not only will contribute to a deeper knowledge of the functionality of the gut in these children but also may provide new approaches to improve the control of the disease. Faecal protein extracts collected from three T1D children (aged 9.3±0.6 years) and three Control children (aged 9.3±1.5 years) were analysed using a combination of 2D gel electrophoresis and spectral counting. The results evidenced markedly differences between the intestinal proteome of T1D children and the Control. The T1D microbial intestinal proteome was enriched with proteins of clostridial cluster XVa and cluster IV and Bacteroides. In contrast, the Control proteome was enriched with bifidobacterial proteins. In both groups, proteins with moonlight function were observed. Human proteins also distinguished the two groups with T1D children depleted in exocrine pancreatic enzymes.

摘要

在本研究中,将已确诊的1型糖尿病(T1D)患儿的肠道微生物蛋白质组与健康儿童(对照组)的蛋白质组进行比较,目的是确定肠道微生物群活性的差异,这不仅有助于更深入了解这些儿童肠道的功能,还可能提供改善疾病控制的新方法。使用二维凝胶电泳和光谱计数相结合的方法,对从三名T1D患儿(年龄9.3±0.6岁)和三名对照儿童(年龄9.3±1.5岁)收集的粪便蛋白质提取物进行分析。结果表明,T1D患儿与对照组的肠道蛋白质组存在明显差异。T1D微生物肠道蛋白质组富含梭菌属XVa簇、IV簇和拟杆菌属的蛋白质。相比之下,对照组蛋白质组富含双歧杆菌属蛋白质。在两组中均观察到具有兼职功能的蛋白质。人类蛋白质也区分了两组,T1D患儿的外分泌胰腺酶含量较低。

相似文献

1
The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins.糖尿病患儿和对照儿童的肠道蛋白质组富含不同的微生物蛋白和宿主蛋白。
Microbiology (Reading). 2017 Feb;163(2):161-174. doi: 10.1099/mic.0.000412.
2
Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.丁酸梭菌生物合成酶在非肥胖型糖尿病小鼠肠道微生物群中明显耗竭。
mSphere. 2018 Oct 24;3(5):e00492-18. doi: 10.1128/mSphere.00492-18.
3
Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes.探索 1 型糖尿病中宿主基因组、表观基因组和肠道微生物组的三重相互作用。
Int J Mol Sci. 2020 Dec 24;22(1):125. doi: 10.3390/ijms22010125.
4
Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.肠道宏蛋白质组学揭示 1 型糖尿病风险人群中的宿主-微生物相互作用。
Diabetes Care. 2018 Oct;41(10):2178-2186. doi: 10.2337/dc18-0777. Epub 2018 Aug 12.
5
Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.1型糖尿病风险的意大利β细胞自身免疫性儿童肠道通透性与粪便微生物群组成之间的关联。
Diabetes Metab Res Rev. 2016 Oct;32(7):700-709. doi: 10.1002/dmrr.2790. Epub 2016 Mar 30.
6
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.1 型糖尿病和 MODY2 患儿与健康对照儿童的肠道微生物群在组成和功能上存在差异:一项病例对照研究。
Diabetes Care. 2018 Nov;41(11):2385-2395. doi: 10.2337/dc18-0253. Epub 2018 Sep 17.
7
The gut microbiota in type 1 diabetes: friend or foe?1 型糖尿病中的肠道微生物群:敌是友?
Curr Opin Endocrinol Diabetes Obes. 2019 Aug;26(4):207-212. doi: 10.1097/MED.0000000000000483.
8
Iron supplementation promotes gut microbiota metabolic activity but not colitis markers in human gut microbiota-associated rats.补铁可促进肠道微生物群代谢活性,但不能改善肠道微生物群相关大鼠的结肠炎标志物。
Br J Nutr. 2014 Jun 28;111(12):2135-45. doi: 10.1017/S000711451400021X. Epub 2014 Feb 21.
9
Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome.维生素D受体缺乏导致肠道菌群失调并改变小鼠肠道微生物组的功能。
Clin Ther. 2015 May 1;37(5):996-1009.e7. doi: 10.1016/j.clinthera.2015.04.004.
10
Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes.益生元对 1 型糖尿病患儿肠道菌群、肠道通透性和血糖控制的影响。
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4427-4440. doi: 10.1210/jc.2019-00481.

引用本文的文献

1
Mutual modulation of gut microbiota and the immune system in type 1 diabetes models.1 型糖尿病模型中肠道微生物群和免疫系统的相互调节。
Nat Commun. 2023 Nov 27;14(1):7770. doi: 10.1038/s41467-023-43652-x.
2
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review.肠道微生物群、肠道通透性和全身炎症:叙述性综述。
Intern Emerg Med. 2024 Mar;19(2):275-293. doi: 10.1007/s11739-023-03374-w. Epub 2023 Jul 28.
3
In vitro gut microbiome response to carbohydrate supplementation is acutely affected by a sudden change in diet.
体外肠道微生物群对碳水化合物补充的反应会受到饮食突然变化的急性影响。
BMC Microbiol. 2023 Jan 28;23(1):32. doi: 10.1186/s12866-023-02776-2.
4
Functional and Taxonomic Traits of the Gut Microbiota in Type 1 Diabetes Children at the Onset: A Metaproteomic Study.1 型糖尿病患儿发病时肠道微生物群的功能和分类特征:一项代谢蛋白质组学研究。
Int J Mol Sci. 2022 Dec 15;23(24):15982. doi: 10.3390/ijms232415982.
5
Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.粪便微生物群移植治疗自身免疫性疾病和自身炎症性疾病的安全性和有效性:系统评价和荟萃分析。
Front Immunol. 2022 Sep 30;13:944387. doi: 10.3389/fimmu.2022.944387. eCollection 2022.
6
Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study.地理位置对埃及1型糖尿病患儿肠道微生物群特征的影响:一项初步研究。
Int J Gen Med. 2022 Jul 15;15:6173-6187. doi: 10.2147/IJGM.S361169. eCollection 2022.
7
Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions.营养保健品对肠道微生物群的调节作用:现状与未来方向
Front Pharmacol. 2022 Mar 18;13:841782. doi: 10.3389/fphar.2022.841782. eCollection 2022.
8
Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study.肠道微生物群与自身免疫性疾病的因果关系:两样本孟德尔随机化研究。
Front Immunol. 2022 Jan 24;12:746998. doi: 10.3389/fimmu.2021.746998. eCollection 2021.
9
Metaproteomics Approach and Pathway Modulation in Obesity and Diabetes: A Narrative Review.代谢组学方法及其在肥胖和糖尿病中的途径调节:叙事性综述。
Nutrients. 2021 Dec 23;14(1):47. doi: 10.3390/nu14010047.
10
The Role of the Gut Microbiota in the Pathogenesis of Diabetes.肠道微生物群在糖尿病发病机制中的作用。
Int J Mol Sci. 2022 Jan 1;23(1):480. doi: 10.3390/ijms23010480.